The company manufactures and trades furnishing fabrics and garments, and is currently attempting to pivot into information technology services and electronic product trading.
The company lacks any identifiable competitive advantage, as evidenced by massive accumulated losses, negative net margins exceeding 40%, and a total cessation of manufacturing operations noted by auditors. The business operates as a commodity textile player with no pricing power, now attempting a desperate shift into unrelated IT services.
Management has overseen significant value destruction, with capital tied up in non-moving inventory and doubtful trade receivables. Recent plans involve diversifying into IT services despite a lack of proven expertise or successful track record in their core textile business.
The company's pivot from a failed textile operation into IT services proved to be a desperate 'hail mary' that lacked both competence and capital. The material uncertainty regarding its status as a going concern culminated in a total liquidity crunch as lenders refused to settle debts and trade receivables were never recovered. By the five-year mark, the accumulated losses and statutory defaults led to a final cessation of all corporate activity, leaving equity holders with a shell company that possesses neither assets nor operations.
RichFakir rates Gravity (India) Ltd's business quality as poor — 25/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Gravity (India) Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Gravity (India) Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Gravity (India) Ltd's fair value is about ₹1 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →